Sox2 Expression Predicts Poor Survival of Hepatocellular Carcinoma Patients and It Promotes Liver Cancer Cell Invasion by Activating Slug

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2013 Feb 23

PMID 23430442

Citations 63

Authors

Chun Sun

Lu Sun

Yan Li

Xiaonan Kang

Shu Zhang

Yinkun Liu

Affiliations

Soon will be listed here.

Abstract

Sox2 is a major transcription factor essential to the stemness characteristics and is associated with various types of cancers. In this study, we investigated the expressions and functional roles of Sox2 in hepatocellular carcinoma (HCC). Our data show that high level of Sox2 expression correlates with metastasis and low survival rate in HCC. HCC cells overexpressing Sox2 are characterized by active epithelial-mesenchymal transition and exhibit increased ability of transwell invasion, soft agar colonization, and sphere formation. We also found Sox2 expression was correlated with the transcription activity of SLUG promoter region. These results present novel mechanistic insight into an important role of Sox2 in HCC and suggest a potential application of Sox2 in HCC prognosis and treatment.

Citing Articles

The molecular pathogenesis of SOX2 in prostate cancer.

Liu S, Yu H, Zhao Z Discov Oncol. 2025; 16(1):215.

PMID: 39976818 PMC: 11842661. DOI: 10.1007/s12672-025-01972-y.

The Application of Molecular Techniques for Assessment of SOX2 and miR126 Expression as Prognostic Markers in Esophageal Carcinoma.

Gharib A, Elsawy W, Alrehaili A, Amin H, Alhuthali H, Bakhuraysah M Comput Math Methods Med. 2024; 2022:1514412.

PMID: 39290848 PMC: 11407893. DOI: 10.1155/2022/1514412.

A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma.

Liu L, Chen J, Ye F, Yan Y, Wang Y, Wu J Technol Cancer Res Treat. 2024; 23:15330338241276895.

PMID: 39155614 PMC: 11331574. DOI: 10.1177/15330338241276895.

Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells.

Baek J, Nam A, Kim K, Kim P Int J Mol Sci. 2024; 25(5).

PMID: 38474121 PMC: 10932193. DOI: 10.3390/ijms25052876.

Epigenetic reprogramming of a distal developmental enhancer cluster drives SOX2 overexpression in breast and lung adenocarcinoma.

Abatti L, Lado-Fernandez P, Huynh L, Collado M, Hoffman M, Mitchell J Nucleic Acids Res. 2023; 51(19):10109-10131.

PMID: 37738673 PMC: 10602899. DOI: 10.1093/nar/gkad734.

References

Alonso M, Diez-Valle R, Manterola L, Rubio A, Liu D, Cortes-Santiago N . Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One. 2011; 6(11):e26740. PMC: 3206066. DOI: 10.1371/journal.pone.0026740. View

Huang P, Qiu J, Li B, Hong J, Lu C, Wang L . Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin Biochem. 2011; 44(8-9):582-9. DOI: 10.1016/j.clinbiochem.2011.02.012. View

Gupta P, Chaffer C, Weinberg R . Cancer stem cells: mirage or reality?. Nat Med. 2009; 15(9):1010-2. DOI: 10.1038/nm0909-1010. View

Camp E, Findlay V, Vaena S, Walsh J, Lewin D, Turner D . Slug expression enhances tumor formation in a noninvasive rectal cancer model. J Surg Res. 2011; 170(1):56-63. PMC: 3134530. DOI: 10.1016/j.jss.2011.02.012. View

Lin T, Ding Y, Li J . Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma. Med Oncol. 2011; 29(2):878-85. DOI: 10.1007/s12032-011-9860-9. View

Alves C, Carneiro F, Hoefler H, Becker K . Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci (Landmark Ed). 2009; 14(8):3035-50. DOI: 10.2741/3433. View

Uchikado Y, Natsugoe S, Okumura H, Setoyama T, Matsumoto M, Ishigami S . Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 2005; 11(3):1174-80. View

Basu-Roy U, Seo E, Ramanathapuram L, Rapp T, Perry J, Orkin S . Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene. 2011; 31(18):2270-82. PMC: 3243769. DOI: 10.1038/onc.2011.405. View

Zhou X, Zhou Y, Huang G, Gong B, Yang B, Zhang D . Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma. Int J Gynecol Pathol. 2011; 30(3):262-70. PMC: 3077452. DOI: 10.1097/PGP.0b013e3182055a1f. View

10.

Jia X, Li X, Xu Y, Zhang S, Mou W, Liu Y . SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J Mol Cell Biol. 2011; 3(4):230-8. DOI: 10.1093/jmcb/mjr002. View

11.

Fu J, Chen Y, Cao J, Luo T, Qian Y, Yang W . p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology. 2011; 53(1):181-92. DOI: 10.1002/hep.24015. View

12.

Yasuda H, Tanaka K, Okita Y, Araki T, Saigusa S, Toiyama Y . CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer. Oncol Lett. 2012; 2(6):1065-1071. PMC: 3406567. DOI: 10.3892/ol.2011.415. View

13.

Li X, Eishi Y, Bai Y, Sakai H, Akiyama Y, Tani M . Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol. 2004; 24(2):257-63. View

14.

Rodriguez-Pinilla S, Sarrio D, Moreno-Bueno G, Rodriguez-Gil Y, Martinez M, Hernandez L . Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol. 2007; 20(4):474-81. DOI: 10.1038/modpathol.3800760. View

15.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

16.

Sun T, Zhao N, Zhao X, Gu Q, Zhang S, Che N . Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2009; 51(2):545-56. DOI: 10.1002/hep.23311. View

17.

Fang X, Yoon J, Li L, Yu W, Shao J, Hua D . The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics. 2011; 12:11. PMC: 3022822. DOI: 10.1186/1471-2164-12-11. View

18.

Peter M . Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle. 2009; 8(6):843-52. PMC: 2688687. DOI: 10.4161/cc.8.6.7907. View

19.

Yang M, Chen C, Chau G, Chiou S, Su C, Chou T . Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology. 2009; 50(5):1464-74. DOI: 10.1002/hep.23221. View

20.

Sanada Y, Yoshida K, Ohara M, Oeda M, Konishi K, Tsutani Y . Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or.... Pancreas. 2006; 32(2):164-70. DOI: 10.1097/01.mpa.0000202947.80117.a0. View